[July 11, 2011] |
|
Cowen Group Announces New Hire to Health Care Research Group
NEW YORK --(Business Wire)--
Cowen Group, Inc. ("Cowen") (NASDAQ: COWN) today announced that Joshua
Jennings has joined the firm as a Senior Research Analyst, where he will
cover cardiology and orthopedic companies in the Medical Technology
sector of Cowen's Research group. Dr. Jennings will be based in New York
and will report to Barry Tarasoff, Cowen's Director of Research.
"We are pleased to welcome Josh to the firm," commented Barry Tarasoff.
"He has strong practical experience in the medical field and has
developed a reputation for providing solid research in a specialized
sector of the life sciences. He brings the type of institutional and
practical knowledge that enables us to deepen our coverage base and
offer a wider area of expertise in ouralready formidable Health Care
research group."
Dr. Jennings joins Cowen and Company from Jefferies & Company, where he
was a Senior Medical Technology Analyst with a coverage universe
consisting of large, mid-, and small-cap medical device companies. Prior
to this, Dr. Jennings was the Attending Physician at Massachusetts
General Hospital and North Shore Children's Hospital Emergency Room. Dr.
Jennings received a B.A. in Biology from Yale University and his M.D.
from Temple University School of Medicine, before doing his residency at
Harvard Medical School.
About Cowen Group, Inc.
Cowen Group, Inc. is a leading diversified financial services firm
providing alternative investment management, investment banking,
research, and sales and trading services through its business units,
Ramius and Cowen and Company. Its alternative investment management
products include hedge funds, fund of funds, real estate funds,
healthcare royalty funds, cash management and commodity trading funds,
offered primarily under the Ramius name. Cowen and Company offers
industry focused investment banking for growth-oriented companies,
domain knowledge-driven research and a sales and trading platform for
institutional investors. Founded in 1918, the firm is headquartered in
New York City and has offices located in major financial centers around
the world.
[ Back To TMCnet.com's Homepage ]
|